|
|
供應(yīng) LDK378 /1032900-25-6 |
規(guī) 格: |
克 |
價(jià) 格: |
1/ |
數(shù) 量: |
999 |
交貨地: |
全國(guó) |
發(fā)布時(shí)間: |
2015-11-03 |
有效期: |
255天 |
備 注: |
CAS NO. 1032900-25-6
英文品名 LDK378
中文品名 色瑞替尼
分子式 C28H36ClN5O3S
分子量 558.14
規(guī)格/純度 98%
供應(yīng)能力 can supply large quantity in kgs scale
別名 LDK 378; LDK-378; Ceritinib
產(chǎn)品簡(jiǎn)述 LDK378 is a highly selective inhibitor of an important cancer target, anaplastic lymphoma kinase (ALK) .
詳細(xì)說(shuō)明 LDK378 is a highly selective inhibitor of an important cancer target, anaplastic lymphoma kinase (ALK) . LDK378 has received Breakthrough Therapy designation by the US Food and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who had progressed during treatment with, or were intolerant to, crizotinib. Approximately 3-8% of patients with NSCLC have the ALK gene mutation [1]. There are limited tr
|
結(jié)構(gòu)式: |
|
|
|